Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro-esophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00666978
What this trial is testing

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Lisa Sanderson Cox, PhD 540
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Not applicableUnknownNCT04657848
What this trial is testing

Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy

Who this might be right for
Gastric CancerReflux Esophagitis
Zhejiang Cancer Hospital 100
Early research (Phase 1)Study completedNCT00252889
What this trial is testing

Doxil Topotecan Doublet Cancer Study

Who this might be right for
Small Cell Lung CancerPancreatic CancerHead and Neck Cancer+2 more
Christiana Care Health Services 20
Not applicableStudy completedNCT02722785
What this trial is testing

PeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal Junction

Who this might be right for
Gastro-esophageal Cancer
Jesper Frank Christensen, PhD 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03448835
What this trial is testing

Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)

Who this might be right for
Stomach CancerGastro Esophageal Junction Cancer
The Netherlands Cancer Institute 20
Not applicableUnknownNCT01044511
What this trial is testing

Quality of Life With Esophageal Stent Trial

Who this might be right for
Esophageal CancerGastro-esophageal Junction Cancer
Michael Bau Mortensen 80
Testing effectiveness (Phase 2)UnknownNCT02924909
What this trial is testing

Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer

Who this might be right for
Esophageal CancerInduction Chemotherapy
Instituto Nacional de Cancer, Brazil 50
Not applicableNot Yet RecruitingNCT07260734
What this trial is testing

AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)

Who this might be right for
OESOPHAGO-GASTRIC CARCINOMAOesophageal AdenocarcinomaGastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma+5 more
Imperial College London 6,000
Testing effectiveness (Phase 2)Ended earlyNCT00064259
What this trial is testing

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)Study completedNCT00719550
What this trial is testing

AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric CancerEsophageal Cancer
Amgen 130
Testing effectiveness (Phase 2)Study completedNCT00003055
What this trial is testing

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT01523015
What this trial is testing

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Who this might be right for
Adenocarcinoma of the Gastroesophageal Junction
Medical University of Lublin 100
Not applicableStudy completedNCT03611309
What this trial is testing

Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members

Who this might be right for
Gastrointestinal Cancer
Stanford University 379
Large-scale testing (Phase 3)Ended earlyNCT01433861
What this trial is testing

Laparoscopy-assisted Proximal Gastrectomy Versus and Laparoscopy-assisted Total Gastrectomy

Who this might be right for
Gastric Cancer
Seoul National University Bundang Hospital 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06374888
What this trial is testing

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Who this might be right for
Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
Convalife (Shanghai) Co., Ltd. 28
Testing effectiveness (Phase 2)Looking for participantsNCT07749586
What this trial is testing

Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Arvinas Inc. 499
Large-scale testing (Phase 3)UnknownNCT02509286
What this trial is testing

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus

Who this might be right for
Esophageal Adenocarcinoma (UICC TNM7)Adenocarcinoma of the Esophagogastric Junction
University Hospital Schleswig-Holstein 438
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Next Page